V8 Peptides — Engineered Performance
Research Library
What Is LL-37 Peptide? A Plain-Language Research Explainer
LL-37ExplainerAntimicrobial Peptides

What Is LL-37 Peptide? A Plain-Language Research Explainer

V8 Peptides Research TeamNovember 15, 2026

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer: LL-37 is a 37-residue, cationic, amphipathic peptide released from the precursor protein hCAP18, the only cathelicidin made by humans. It is named for the two leucines that begin its sequence and its chain length. In laboratory work it is studied for how it disrupts bacterial membranes and how it signals to immune cells. It is a research compound only. This explainer covers where it comes from, what the preclinical literature examines, how it compares with KPV, and what to check on a certificate of analysis. The 10 mg vial is coming soon to the V8 catalog.

Where the name LL-37 comes from

The name is a structural shorthand. LL-37 begins with the residues Leu-Leu and is 37 amino acids long. Its sequence is LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES. The chain carries a net positive charge at neutral pH because of its many lysine and arginine side chains, and roughly a third of its residues are hydrophobic. That mix of charge and oily surface is why it folds into an alpha-helix when it meets a membrane-like environment.

The gene was first described in the mid-1990s, when researchers searching human bone marrow cDNA found a cathelicidin-family sequence and showed that its precursor is cut inside granulocytes to release the C-terminal peptide (PMID 8681941). Older papers sometimes call the molecule FALL-39, the original 39-residue designation before the two N-terminal residues were found to be absent from the main product.

Freeze-dried peptides are normally shipped as a dry cake, which is the form discussed throughout this article.

From hCAP18 to LL-37

Humans have a single cathelicidin gene, CAMP. It encodes a pre-pro-protein with a signal sequence, a conserved N-terminal cathelin domain and the C-terminal antimicrobial domain. The stored precursor is called hCAP18. In neutrophil granules it sits as an inactive protein, and after release the enzyme proteinase 3 cleaves it extracellularly to free LL-37 (PMID 11389039).

This matters for experimental design because the same precursor can be cut at different positions in different tissues, giving shorter fragments with their own properties. A synthetic full-length LL-37 reference is therefore not identical to every natural cathelicidin product, and papers should be read with that in mind.

Expression is not limited to neutrophils. Epithelial cells from skin, airway and gut also express the gene in cell and tissue models, which is one reason the peptide shows up in so many different research fields.

Membrane disruption: the best-characterized theme

The classic LL-37 question is how a short cationic helix damages bacterial membranes. Biophysical work with model phospholipid membranes found that the peptide lies parallel to the bilayer surface and, once enough of it has accumulated, destabilizes the membrane in a carpet-like way rather than forming a tidy barrel-shaped pore (PMID 10417311). Negative charges on bacterial surfaces attract the positively charged peptide, while the more neutral, cholesterol-rich outer leaflet of mammalian cells is a poorer target in the same assays.

Other in-vitro observations include self-association into oligomers in solution, sensitivity to salt and serum components, and binding to lipopolysaccharide, the outer-membrane molecule of Gram-negative bacteria. Because activity depends so heavily on buffer composition, a result from one assay medium does not transfer cleanly to another. That is a practical lesson when designing minimum-inhibitory-concentration experiments with any cationic peptide.

Membranes are not the whole story. Studies have also used biofilm models to ask whether sub-lethal exposure changes bacterial attachment to surfaces, and have examined how bacteria resist cationic peptides by altering surface charge or secreting proteases.

Immune signaling research

LL-37 is often called a multifunctional host-defense peptide because experiments have attributed many signaling roles to it. A widely cited early finding is that it acts through the receptor FPRL1 (also called FPR2) to attract neutrophils, monocytes and T cells in chemotaxis assays (PMID 11015447). Later work has examined P2X7 purinergic signaling, transactivation of the epidermal growth factor receptor, and interaction with toll-like receptor pathways, mostly in cultured cells.

A comprehensive review catalogs these findings, including cytokine release, effects on dendritic-cell maturation, angiogenesis models and wound-closure assays in cultured keratinocytes (PMID 23246832). It also records that some reports point in opposite directions: the peptide looks pro-inflammatory in one model and dampening toward lipopolysaccharide responses in another. Cell type, concentration and the presence of serum all seem to shift the outcome.

Everything described here is in-vitro or animal-model work. Nothing in this article is a statement about what the peptide does in a person, and the conflicting results are a reminder to read primary papers instead of summaries.

LL-37 and KPV at a glance

LL-37 and KPV are both used as tools in antimicrobial and inflammation research models, but they are very different molecules. LL-37 is a long, amphipathic, membrane-active peptide. KPV is a three-residue fragment from the C-terminus of alpha-MSH, and its literature leans toward intracellular signaling and transporter uptake. The table lists basic descriptors only.

CompoundLengthOriginTypical research context
LL-3737 residues (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES)C-terminal domain of hCAP18, the human cathelicidinMembrane-disruption assays, chemotaxis and cytokine readouts in cell models
KPV3 residues (Lys-Pro-Val)C-terminus of alpha-MSHIn-vitro antimicrobial and inflammation-signaling models, epithelial transport studies
hCAP18About 170 residues, including the cathelin domainPrecursor stored in neutrophil granulesProcessing and protease studies

For the smaller peptide, see what KPV is, the KPV antimicrobial in-vitro background and the KPV product page.

Handling the lyophilized powder

LL-37 is supplied as a freeze-dried powder, and the general rules for lyophilized peptides apply. Keep sealed vials cold, dry and away from light, avoid repeated temperature cycling, and note the date a vial is first opened. Highly basic peptides can attract moisture, so letting a cold vial come to room temperature before opening limits condensation on the powder.

Cationic, helical peptides also tend to stick to plastic and glass surfaces at low concentrations, and they can aggregate in some buffers. Researchers often record the container material and buffer in their methods for that reason. Preparing solutions is covered in how to reconstitute a lyophilized peptide, and amounts can be worked out with the peptide calculator.

What to check on an LL-37 certificate of analysis

At 37 residues with many repeated basic and hydrophobic residues, LL-37 is a demanding synthesis. Deletion and truncated sequences are a realistic impurity, so the documentation deserves a careful read.

HPLC purity with the chromatogram, not only a percentage. Check whether minor peaks are visible and how they were integrated. Understanding HPLC purity explains the numbers.

Identity confirmation. As generic buying guidance, ask which method confirms that the measured molecular weight matches the expected value of about 4.49 kDa, and look for the result in the report.

Lot reference and date that match the vial, plus the name of the testing laboratory.

Stated fill amount, and whether it refers to total powder or net peptide content.

Counter-ion and residual salts. Trifluoroacetate or acetate content can matter in cell assays, because some cell types respond to the counter-ion itself.

V8 Peptides sells its products for laboratory research use only, and certificates of analysis for tested lots are published on the COA page. A walk-through of each section is in how to read a COA. LL-37 is listed on its product page as a 10 mg vial, and the wider range is in the catalog.

Common misunderstandings

“LL-37 is just an antibiotic peptide.” Killing bacteria in a dish is one documented activity. The literature is at least as much about receptor signaling and immune-cell behavior.

“LL-37 and hCAP18 are the same thing.” hCAP18 is the precursor. LL-37 is the C-terminal piece that is released after cleavage.

“Results in one assay buffer apply everywhere.” Salt, divalent cations and serum change the measured activity of cationic peptides substantially.

“KPV and LL-37 do the same thing.” They share a broad research theme, not a mechanism or a size.

“Cell and animal data predict human outcomes.” They do not, and this article makes no such claim.

Frequently asked questions

What is LL-37?

A 37-residue cationic peptide released from the human cathelicidin precursor hCAP18, studied in the laboratory for membrane disruption and immune-cell signaling.

What does the name LL-37 mean?

It reflects the two leucines at the start of the sequence and the total length of 37 amino acids.

What is the difference between hCAP18 and LL-37?

hCAP18 is the inactive stored precursor. LL-37 is the C-terminal antimicrobial fragment freed when proteinase 3 or another enzyme cleaves it.

How does LL-37 interact with membranes in research models?

Biophysical studies describe a helical peptide that lies along the membrane surface and destabilizes it in a carpet-like manner, preferring negatively charged bacterial-type membranes.

How is LL-37 different from KPV?

LL-37 is a long, amphipathic, membrane-active peptide. KPV is a three-residue alpha-MSH fragment studied mostly for intracellular signaling and transporter uptake.

What is the molecular weight of LL-37?

About 4.49 kDa for the free peptide, which is a useful number to compare with the identity data on a certificate of analysis.

Why do LL-37 results vary between laboratories?

Activity depends strongly on salt, serum, buffer and container material, so assay conditions differ more than the peptide does.

Is LL-37 sold by V8 Peptides?

V8 Peptides sells its products for laboratory research use only, not for human or animal consumption. The LL-37 listing is a 10 mg vial.

What should I look for on an LL-37 COA?

An HPLC chromatogram, an identity method with a measured mass near the expected value, a lot reference matching the vial, a test date and a named laboratory.

How is lyophilized LL-37 stored?

Sealed, cold, dry and protected from light, with temperature cycling avoided and the opening date recorded.

References

  1. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem. 1996;238(2):325-332. PMID: 8681941.
  2. Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J. 1999;341(Pt 3):501-513. PMID: 10417311.
  3. Sorensen OE, Follin P, Johnsen AH, et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001;97(12):3951-3959. PMID: 11389039.
  4. De Yang, Chen Q, Schmidt AP, et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med. 2000;192(7):1069-1074. PMID: 11015447.
  5. Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012;280(1):22-35. PMID: 23246832.

All V8 Peptides products are sold for laboratory research use only. They are not drugs, foods, or cosmetics and are not intended for human or animal consumption.

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.